Total Payments
$185,673
2024 Payments
$78,787
Companies
11
Transactions
130
Payment Breakdown by Category
Consulting$129,330 (69.7%)
Travel$42,260 (22.8%)
Research$8,702 (4.7%)
Other$3,486 (1.9%)
Food & Beverage$1,882 (1.0%)
Education$14.50 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $129,330 | 44 | 69.7% |
| Travel and Lodging | $42,260 | 41 | 22.8% |
| Unspecified | $8,702 | 7 | 4.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,286 | 2 | 1.2% |
| Food and Beverage | $1,882 | 33 | 1.0% |
| Honoraria | $1,200 | 2 | 0.6% |
| Education | $14.50 | 1 | 0.0% |
Payments by Type
General
$176,972
123 transactions
Research
$8,702
7 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ModernaTX, Inc. | $45,397 | 6 | $0 (2024) |
| SANOFI PASTEUR INC. | $40,312 | 34 | $0 (2022) |
| PFIZER INC. | $34,205 | 16 | $0 (2024) |
| AstraZeneca UK Limited | $21,322 | 17 | $0 (2023) |
| Merck Sharp & Dohme LLC | $14,783 | 19 | $0 (2024) |
| GlaxoSmithKline, LLC. | $9,524 | 13 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $5,794 | 16 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $4,225 | 1 | $0 (2021) |
| Genentech, Inc. | $4,202 | 4 | $0 (2019) |
| ABBVIE INC. | $3,750 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $78,787 | 26 | ModernaTX, Inc. ($43,797) |
| 2023 | $11,307 | 12 | PFIZER INC. ($5,357) |
| 2022 | $27,774 | 19 | AstraZeneca UK Limited ($17,822) |
| 2021 | $16,752 | 8 | SANOFI PASTEUR INC. ($8,027) |
| 2020 | $13,685 | 7 | SANOFI PASTEUR INC. ($9,435) |
| 2019 | $17,280 | 40 | GlaxoSmithKline, LLC. ($4,732) |
| 2018 | $18,282 | 11 | Sanofi Pasteur Inc. ($16,290) |
| 2017 | $1,808 | 7 | SANOFI PASTEUR INC. ($1,808) |
All Payment Transactions
130 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/28/2024 | PFIZER INTERNATIONAL LLC | ABRYSVO (Biological) | Travel and Lodging | In-kind items and services | $759.11 | General |
| Category: VACCINES | ||||||
| 11/28/2024 | PFIZER INTERNATIONAL LLC | ABRYSVO (Biological) | Travel and Lodging | In-kind items and services | $696.28 | General |
| Category: VACCINES | ||||||
| 11/15/2024 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| 11/04/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $2,325.00 | General |
| 10/28/2024 | Merck Sharp & Dohme LLC | — | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| 10/16/2024 | Merck Sharp & Dohme LLC | — | Travel and Lodging | In-kind items and services | $282.56 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/16/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $64.99 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/16/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $55.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/16/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/15/2024 | ModernaTX, Inc. | Moderna Covid-19 Vaccine (Biological) | Consulting Fee | Cash or cash equivalent | $40,740.00 | General |
| Category: Infections and Infectious Diseases | ||||||
| 10/15/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $123.75 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/11/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $1,950.00 | General |
| 09/24/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $650.00 | General |
| 08/08/2024 | PFIZER INC. | — | Consulting Fee | Cash or cash equivalent | $4,000.00 | General |
| 04/30/2024 | PFIZER INC. | ABRYSVO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| Category: VACCINES | ||||||
| 04/25/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $1,950.00 | General |
| 03/14/2024 | PFIZER INC. | ABRYSVO (Biological) | Travel and Lodging | Cash or cash equivalent | $469.12 | General |
| Category: VACCINES | ||||||
| 03/11/2024 | ModernaTX, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| 03/11/2024 | ModernaTX, Inc. | — | Travel and Lodging | Cash or cash equivalent | $234.81 | General |
| 03/11/2024 | ModernaTX, Inc. | — | Food and Beverage | Cash or cash equivalent | $17.72 | General |
| 03/11/2024 | ModernaTX, Inc. | — | Travel and Lodging | Cash or cash equivalent | $4.59 | General |
| 03/01/2024 | PFIZER INC. | ABRYSVO (Biological) | Consulting Fee | Cash or cash equivalent | $9,790.00 | General |
| Category: VACCINES | ||||||
| 02/26/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $1,860.00 | General |
| 02/13/2024 | PFIZER INC. | ABRYSVO (Biological) | Travel and Lodging | In-kind items and services | $6,484.04 | General |
| Category: VACCINES | ||||||
| 01/26/2024 | AstraZeneca Pharmaceuticals LP | FLUMIST QUADRIVALENT (Biological) | Consulting Fee | Cash or cash equivalent | $550.00 | General |
| Category: Respiratory | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| BNT162 CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $8,460 | 5 |
| EPI-RSV-005 BOD | GlaxoSmithKline, LLC. | $241.56 | 2 |
About Janet Englund
Janet Englund is a Pediatric Infectious Diseases healthcare provider based in Seattle, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679663561.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Janet Englund has received a total of $185,673 in payments from pharmaceutical and medical device companies, with $78,787 received in 2024. These payments were reported across 130 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($129,330).
Ad
Practice Information
- Specialty Pediatric Infectious Diseases
- Location Seattle, WA
- Active Since 10/13/2006
- Last Updated 07/08/2007
- Taxonomy Code 2080P0208X
- Entity Type Individual
- NPI Number 1679663561
Products in Payments
- Moderna Covid-19 Vaccine (Biological) $40,740
- NO PRODUCT DISCUSSED (Drug) $20,498
- ABRYSVO (Biological) $19,699
- EVUSHELD (Drug) $11,480
- COMIRNATY (Biological) $8,460
- Xofluza (Drug) $4,202
- PREVYMIS (Drug) $3,941
- MK-4482 (Biological) $2,975
- FLUMIST QUADRIVALENT (Biological) $2,400
- FLUMIST (Biological) $1,600
- PAXLOVID (Drug) $1,200
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Infectious Diseases Doctors in Seattle
Tamara Pozos
Pediatric Infectious Diseases — Payments: $7,531
Pediatric Infectious Diseases $7,531
Dr. Surabhi Vora, Md, MD
Pediatric Infectious Diseases — Payments: $3,904
Pediatric Infectious Diseases $3,904
Michael Gilbert, Md, MD
Pediatric Infectious Diseases — Payments: $328.11
Pediatric Infectious Diseases $328.11
Christopher Wilson
Pediatric Infectious Diseases — Payments: $291.95
Pediatric Infectious Diseases $291.95
Matthew Dellinger, M.d, M.D
Pediatric Infectious Diseases — Payments: $15.74
Pediatric Infectious Diseases $15.74
Ann Melvin
Pediatric Infectious Diseases
Pediatric Infectious Diseases